EUVIMEDEUVIMED entdecken
Crossref

Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain

Ye Yang, Renrong Wu

European Archives of Psychiatry and Clinical Neuroscience · 2025-04 · 275 (3) · 619-627

DOI: 10.1007/s00406-025-01965-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Psychiatry and Clinical Neuroscience, online erschienen am 19.02.2025. Verfasst von Ye Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychosomatics, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, S…. Hauptthemen laut MEDLINE: Antipsychotic Agents, Risperidone, Weight Gain, Benzodiazepines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Research Personnel Cultivation Programme of Zhongda Hospital Southeast University, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate whether antipsychotic medications can cause metabolic abnormalities independent of weight gain. Six hundred twenty-four patients treated with olanzapine and risperidone were enrolled. Body weight, body mass index (BMI), biochemical indicators of blood glucose and lipids, the proportion of patients who gained > 7% of their baseline weight, dyslipidemia, and dysglycemia were evaluated. The association between the prevalence of metabolic disturbances and groups was analyzed using logistic regression, adjusting confounding variables including age, sex, weight, duration and Chlorpromazine (CLO)-equivalent dosage. Assessments were conducted at baseline and 4, 8, and 24-weeks post-treatment. The rate of weight gain > 7% at 8-weeks was significantly higher than at 4-weeks in the total population (F = 49.02, p < 0.001) and in patients with abnormal metabolism (F = 29.97, p < 0.001). No significant differences were observed between follow-up time points in the 24-weeks. The proportion of abnormal blood lipids and glucose did not differ significantly between the 4-week and 8-week follow-ups. Logistic regression analyses revealed significant differences between olanzapine and risperidone groups regarding the prevalence of hypertriglyceridemia at week 4 ([adjusted odds ratio; aOR] = 1.710; 95% [ confidence interval; CI] = 1.213-2.410) and week 8 ([aOR] = 1.594; 95% [CI] = 0.859-2.957) and low LDL at week 4 ([aOR] = 1.772; 95%[CI] = 1.014-3.097) and week 8 ([aOR] = 3.851; 95%[CI] = 1.732-5.588). In conclusion, antipsychotics-induced metabolic abnormalities and weight gain are not fully synchronized, and metabolic abnormalities vary significantly across different atypical antipsychotic medication (AAP) groups, even after adjusting BMI. AAPs may have a direct effect on metabolic parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsRisperidoneWeight GainBenzodiazepinesBlood GlucoseLipid MetabolismHumansMaleFemaleAdultOlanzapineMiddle AgedYoung AdultBody Mass Index

Stichwörter der Autor:innen

Antipsychotic drugsMetabolic abnormalitySchizophreniaWeight gain

Substanzen

Antipsychotic AgentsRisperidoneOlanzapineBenzodiazepinesBlood Glucose

Autor:innen und Institutionen

  • Department of Psychiatry and Psychosomatics, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, 210009, China.
  • Department of Psychiatry, National Center for Mental Disorders, National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China. wurenrong@…

Förderung

  • National Natural Science Foundation of China
  • the Research Personnel Cultivation Programme of Zhongda Hospital Southeast University
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Yang, Y., & Wu, R. (2025). Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain. European Archives of Psychiatry and Clinical Neuroscience, 275(3), 619-627. https://doi.org/10.1007/s00406-025-01965-6

Vancouver

Yang Y, Wu R. Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain. European Archives of Psychiatry and Clinical Neuroscience. 2025;275(3):619-627. doi:10.1007/s00406-025-01965-6

BibTeX
@article{Yang2025,
  author = {Yang, Ye and Wu, Renrong},
  title = {Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain},
  journal = {European Archives of Psychiatry and Clinical Neuroscience},
  year = {2025},
  volume = {275},
  number = {3},
  pages = {619--627},
  doi = {10.1007/s00406-025-01965-6}
}
Kostenlos starten →